Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • luc
    Senior Member
    • Dec 2010
    • 469

    #16
    It seems unlikely that LNA bases would be used - to my knowledge, LNA in the template inhibits most polymerases.
    I assume the phosphorothioate linkage helps predominantly preventing 3’ to 5’ exonuclease activity of the ligase - reducing adapter dimers.
    We too, had good experiences with the Bioo adapters though.

    Comment

    • NextGenSeq
      Senior Member
      • Apr 2009
      • 482

      #17

      Reduction of non-insert sequence reads by dimer eliminator LNA oligonucleotide for small RNA deep sequencing


      Here we describe a method for constructing small RNA libraries for high throughput sequencing in which we have made a significant improvement to commonly available standard protocols. We added a locked nucleic acid (LNA) oligonucleotide—named dimer eliminator—that is complementary to the adapter-dimer ligation products during the reverse transcription reaction. It reduces adapter-dimers, which often contaminate standard libraries and increase the number of non-insert sequence reads.



      Tufts LNA Adapter Protocol

      Comment

      • M4TTN
        Member
        • Jan 2014
        • 77

        #18
        Dear NextGenSeq, (apologies for dragging up an old post!)

        I have a DNA enrichment project where our inserts range from only 40bp and up. We'd like to get them all.

        We've just done a run and it is clear that we have sequenced a lot of adapter dimers (we expected that to be the case from the bioanalyser trace). My question is how applicable your strategy for dimer removal would be to standard Illumina DNA-DNA adapter dimer junctions? From the % base trace on MiSeq reporter it appears that most of the adapter junctions have gained an A (complementary to the overhanging T).

        i.e. the pure adapter dimer junction should be: GCTCTTCCGATC/GATCGGAAGAGC
        But we see (I think): GCTCTTCCGATCtaGATCGGAAGAGC

        Or rather: in the sequence trace we see: AGATCGGAAGAGC...

        And since the read primer ends: ...GCTCTTCCGATCT

        This presumably means that the overhanging T is present (for the read primer to work) and an A has been added upstream of the GATCGGAA...

        So...questions:
        Would an oligo that spans this junction inhibit PCR?
        What is the role of the LNA within this oligo?
        Last edited by M4TTN; 08-09-2016, 10:36 AM.

        Comment

        • nucacidhunter
          Jafar Jabbari
          • Jan 2013
          • 1250

          #19
          Originally posted by M4TTN View Post
          i.e. the pure adapter dimer junction should be: GCTCTTCCGATC/GATCGGAAGAGC
          But we see (I think): GCTCTTCCGATCtaGATCGGAAGAGC

          Or rather: in the sequence trace we see: AGATCGGAAGAGC...

          And since the read primer ends: ...GCTCTTCCGATCT

          This presumably means that the overhanging T is present (for the read primer to work) and an A has been added upstream of the GATCGGAA...

          So...questions:
          Would an oligo that spans this junction inhibit PCR?
          What is the role of the LNA within this oligo?
          I think adapter-dimer formation is more complex. I would suggest analysing a TruSeq Universal and Index adapter for hetero-dimer formation for instance using OligoAnalyzer. You will see that there is more than one way for hetero-dimer formation with relatively low Delta Gs (they will anneal during annealing step) and each of those can be extended and then those products can form new versions of hetero-dimers in the following cycles.

          In your target range the best way for getting rid of dimers is preventing or reducing dimer formation by careful titration of adapters or using dimer-free adapter technology.

          PS. I have not seen any proof that Illumina uses LNA technology in their adapter oligos but LNA will increase the stability of annealed adapter oligos.
          Last edited by nucacidhunter; 08-09-2016, 10:22 PM. Reason: Added more info

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 11:41 AM
          0 responses
          8 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          44 views
          0 reactions
          Last Post SEQadmin2  
          Working...